Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.


All category news

  • Vertex cystic fibrosis drug gets expanded approval for use in infants

    August 15, 2018 8:42 PM 10

    (Reuters) - U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc’s cystic fibrosis drugs to include patients aged between 12 months and 24 months. The expanded approval makes Kalydeco the first medicine to treat the underlying cause of the genetic disease in this age group among patients with specific mutations in the CF transmembrane

  • Getting too little sleep may 'age' the heart

    August 14, 2018 3:45 PM 18

    (Reuters Health) - Adults who sleep too little or too much may have an increased risk of heart attack or stroke, say researchers who argue that the best way to think of the harmful effect is in terms of “excess heart age.” In a nationally representative sample of U.S. adults, those who slept seven hours a night had the lowest heart risk on average, calculated

  • Amicus sets $315,000 price for new Fabry disease treatment

    August 13, 2018 2:27 PM 21

    (Reuters) - Amicus Therapeutics (FOLD.O) on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States. Galafold - approved on Friday by U.S. regulators - is the first new Fabry disease treatment in the country in over 15 years

  • UnitedHealth is buying pharmacy operator Genoa: Axios

    August 8, 2018 7:28 PM 26

    (Reuters) - Health insurer UnitedHealth Group Inc has at least a tentative agreement to buy specialty pharmacy operator Genoa Health from private equity firm Advent International, news website Axios reported, citing a source familiar with the deal. Genoa Chief Executive John Figueroa will move on and Chief Commercial Officer Mark Peterson will run the business

  • U.S. FDA panel backs approval of Paratek's antibiotic

    August 8, 2018 6:12 PM 24

    (Reuters) - A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc’s antibiotic to treat bacterial pneumonia and skin infections. The panel voted 17-1 in favor of the drug’s safety and effectiveness in treating acute bacterial skin and skin structure infections, and voted 14-4 for treating

  • Health workers in Congo being vaccinated against Ebola: WHO

    August 8, 2018 2:05 PM 25

    GENEVA (Reuters) - Vaccination of health workers against the deadly Ebola virus has begun in the Democratic Republic of Congo to try to halt an outbreak in the volatile east of the country, the World Health Organization (WHO) said on Wednesday. So far 43 people are believed to have been infected in North Kivu and Ituri provinces, including 36 who have died, Congo’s

  • Trump says will make announcement next week on reducing drug prices

    August 8, 2018 12:55 AM 25

    BEDMINSTER, N.J. (Reuters) - U.S. President Donald Trump said on Tuesday that his administration would make an announcement next week on reducing drug prices, but he did not offer specifics. Speaking at a dinner with business leaders at his New Jersey club, Trump said, “We are announcing something next week which is going to get them down really substantially

  • Paratek antibiotic not inferior to current treatments: FDA staff

    August 6, 2018 1:16 PM 22

    (Reuters) - Paratek Pharmaceuticals Inc’s new antibiotic for bacterial pneumonia and skin infections is not inferior to current treatments, U.S. Food and Drug Administration staff reviewers said on Monday. If approved, omadacycline will be Paratek’s first drug in the market and also the first of a new class of antibiotics called aminomethylcyclines

  • FDA declines to approve Pain Therapeutics' abuse-deterrent opioid drug

    August 6, 2018 11:44 AM 20

    (Reuters) - Pain Therapeutics said on Monday that the U.S. Food and Drug Administration declined to approve its opioid drug for the management of severe pain as the benefits of the drug did not outweigh the risk. “This is a bizarre conclusion to reach, especially during a time of staggering human and economic toll created by opioid abuse and addiction

  • Malaysia reports H5N1 bird flu outbreak on farm: OIE

    August 6, 2018 10:41 AM 25

    PARIS (Reuters) - Malaysia has reported an outbreak of the highly contagious H5N1 bird flu virus on a farm in the eastern region of Sabah, the World Organisation for Animal Health (OIE) said on Monday, citing a report from Malaysia’s veterinary authorities. The virus killed 3,000 out of 28,000 egg-laying chickens on the farm in Kampung Kauluan and all of the remaining